Alzheimer’s Disease Diagnostics and Treatment Market Size, Share, and Growth Forecast for 2025 - 2032

Table of Content

1. Executive Summary
   1. Global Alzheimer’s Disease Diagnostics & Treatment Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
   3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Solution/Service Adoption Analysis
   2. Disease Epidemiology- Alzheimer
   3. Recent Solution Launch and Approval Insights
   4. Clinical Trials- Pipeline Assessment (Drugs)
   5. Regulatory Landscape
   6. Reimbursement Scenario
   7. PESTLE Analysis
   8. Porter’s Five Force Analysis
   9. Promotional Strategies, By Key Players
   10. Value Chain Analysis
   11. Parent Market Analysis
4. Global Alzheimer’s Disease Diagnostics & Treatment Market Outlook:
   1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2024
      2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
   3. Global Alzheimer’s Disease Diagnostics & Treatment Market Outlook: Solution
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Solution, 2019 - 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Solution, 2025 - 2032
         1. Therapeutics
            1. Cholinesterase Inhibitors
            2. NMDA Receptor Antagonists
            3. Manufactured Combinations
            4. Anti-Amyloid Monoclonal Antibodies
            5. Others
         2. Diagnostics
            1. Cerebrospinal Fluid (CSF) Biomarker Tests
            2. Blood-based Biomarker Tests
            3. Computerized Cognitive Tests and Devices
            4. Brain Imaging Test
            5. Others
      4. Market Attractiveness Analysis: Solution
   4. Global Alzheimer’s Disease Diagnostics & Treatment Market Outlook: Sales Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Sales Channel, 2019 - 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Sales Channel, 2025 - 2032
         1. Retail Sales
            1. Retail Pharmacies
            2. Online Pharmacies
         2. Institutional Sales
            1. Diagnostic Centers
            2. Hospitals
            3. Specialty Clinics
            4. Others
      4. Market Attractiveness Analysis: Sales Channel
5. Global Alzheimer’s Disease Diagnostics & Treatment Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2024
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
6. North America Alzheimer’s Disease Diagnostics & Treatment Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Solution
      3. By Sales Channel
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Solution, 2025 - 2032
      1. Therapeutics
         1. Cholinesterase Inhibitors
         2. NMDA Receptor Antagonists
         3. Manufactured Combinations
         4. Anti-Amyloid Monoclonal Antibodies
         5. Others
      2. Diagnostics
         1. Cerebrospinal Fluid (CSF) Biomarker Tests
         2. Blood-based Biomarker Tests
         3. Computerized Cognitive Tests and Devices
         4. Brain Imaging Test
         5. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Sales Channel, 2025 - 2032
      1. Retail Sales
         1. Retail Pharmacies
         2. Online Pharmacies
      2. Institutional Sales
         1. Diagnostic Centers
         2. Hospitals
         3. Specialty Clinics
         4. Others
   6. Market Attractiveness Analysis
7. Europe Alzheimer’s Disease Diagnostics & Treatment Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Solution
      3. By Sales Channel
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Solution, 2025 - 2032
      1. Therapeutics
         1. Cholinesterase Inhibitors
         2. NMDA Receptor Antagonists
         3. Manufactured Combinations
         4. Anti-Amyloid Monoclonal Antibodies
         5. Others
      2. Diagnostics
         1. Cerebrospinal Fluid (CSF) Biomarker Tests
         2. Blood-based Biomarker Tests
         3. Computerized Cognitive Tests and Devices
         4. Brain Imaging Test
         5. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Sales Channel, 2025 - 2032
      1. Retail Sales
         1. Retail Pharmacies
         2. Online Pharmacies
      2. Institutional Sales
         1. Diagnostic Centers
         2. Hospitals
         3. Specialty Clinics
         4. Others
   6. Market Attractiveness Analysis
8. East Asia Alzheimer’s Disease Diagnostics & Treatment Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Solution
      3. By Sales Channel
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Solution, 2025 - 2032
      1. Therapeutics
         1. Cholinesterase Inhibitors
         2. NMDA Receptor Antagonists
         3. Manufactured Combinations
         4. Anti-Amyloid Monoclonal Antibodies
         5. Others
      2. Diagnostics
         1. Cerebrospinal Fluid (CSF) Biomarker Tests
         2. Blood-based Biomarker Tests
         3. Computerized Cognitive Tests and Devices
         4. Brain Imaging Test
         5. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Sales Channel, 2025 - 2032
      1. Retail Sales
         1. Retail Pharmacies
         2. Online Pharmacies
      2. Institutional Sales
         1. Diagnostic Centers
         2. Hospitals
         3. Specialty Clinics
         4. Others
   6. Market Attractiveness Analysis
9. South Asia & Oceania Alzheimer’s Disease Diagnostics & Treatment Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Solution
      3. By Sales Channel
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Solution, 2025 - 2032
      1. Therapeutics
         1. Cholinesterase Inhibitors
         2. NMDA Receptor Antagonists
         3. Manufactured Combinations
         4. Anti-Amyloid Monoclonal Antibodies
         5. Others
      2. Diagnostics
         1. Cerebrospinal Fluid (CSF) Biomarker Tests
         2. Blood-based Biomarker Tests
         3. Computerized Cognitive Tests and Devices
         4. Brain Imaging Test
         5. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Sales Channel, 2025 - 2032
      1. Retail Sales
         1. Retail Pharmacies
         2. Online Pharmacies
      2. Institutional Sales
         1. Diagnostic Centers
         2. Hospitals
         3. Specialty Clinics
         4. Others
   6. Market Attractiveness Analysis
10. Latin America Alzheimer’s Disease Diagnostics & Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Solution
       3. By Sales Channel
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Solution, 2025 - 2032
       1. Therapeutics
          1. Cholinesterase Inhibitors
          2. NMDA Receptor Antagonists
          3. Manufactured Combinations
          4. Anti-Amyloid Monoclonal Antibodies
          5. Others
       2. Diagnostics
          1. Cerebrospinal Fluid (CSF) Biomarker Tests
          2. Blood-based Biomarker Tests
          3. Computerized Cognitive Tests and Devices
          4. Brain Imaging Test
          5. Others
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Sales Channel, 2025 - 2032
       1. Retail Sales
          1. Retail Pharmacies
          2. Online Pharmacies
       2. Institutional Sales
          1. Diagnostic Centers
          2. Hospitals
          3. Specialty Clinics
          4. Others
    6. Market Attractiveness Analysis
11. Middle East & Africa Alzheimer’s Disease Diagnostics & Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Solution
       3. By Sales Channel
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Solution, 2025 - 2032
       1. Therapeutics
          1. Cholinesterase Inhibitors
          2. NMDA Receptor Antagonists
          3. Manufactured Combinations
          4. Anti-Amyloid Monoclonal Antibodies
          5. Others
       2. Diagnostics
          1. Cerebrospinal Fluid (CSF) Biomarker Tests
          2. Blood-based Biomarker Tests
          3. Computerized Cognitive Tests and Devices
          4. Brain Imaging Test
          5. Others
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Sales Channel, 2025 - 2032
       1. Retail Sales
          1. Retail Pharmacies
          2. Online Pharmacies
       2. Institutional Sales
          1. Diagnostic Centers
          2. Hospitals
          3. Specialty Clinics
          4. Others
    6. Market Attractiveness Analysis
12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. Fujirebio
          1. Overview
          2. Segments and Solutions
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Roche Diagnostics
       3. Cognoptix Inc
       4. Sysmex Corporation
       5. PHC Holdings Corporation
       6. Quest Diagnostic
       7. C2N Diagnostics
       8. Araclon Biotech (Grifols, S.A.)
       9. Quanterix
       10. Beckman Coulter, Inc.
       11. Laboratory Corporation of America® Holdings
       12. Eli Lilly and Company
       13. Others
13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations